MedicineCarcinomaNon-Small-Cell LungMolecular Docking SimulationHumansLung Neoplasms
Exploring the mechanism of Kanglixin capsules in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking.
Yilong Li, Mingxuan Li, Xu Gong, Kangwei Xia, Zhaorui Liu, Xiangjun Qiu
Published: 202510.1097/MD.0000000000044768
Abstract
This study explores the mechanism of action of KangLiXin capsule (KLX) in the intervention of non-small cell lung cancer (NSCLC) using network pharmacology and molecular docking methods to identify its potential targets and pathways, provide new dire…
Preview only. Read the full abstract at the source